Clinical Trial Update: Identifying Low-Risk Patients With Pulmonary Embolism

View source ↗

Summary

Clinical trial update noting a completed study aimed at identifying low-risk patients with pulmonary embolism. The sponsor is the National Heart, Lung, and Bloo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Pulmonary Embolism, Lung Diseases | Status: COMPLETED